Transfuse OTL-103 in Periph Vein, Perc, New Tech 8

This code describes the administration of OTL-103, a novel therapeutic agent, directly into a peripheral vein. The procedure is performed percutaneously, meaning through the skin, typically using a needle or catheter without requiring an open incision. This represents a new technology procedure, specifically categorized within Group 8.

This code is appropriate for documenting the intravenous delivery of OTL-103 for conditions where this specific agent is indicated, such as certain genetic disorders or cancers, as part of a clinical trial or approved therapy. It should be used when the administration is via a peripheral access site, like an arm or hand vein, rather than a central line.

• Verify that OTL-103 is the specific substance being transfused, as other new technology agents will have different codes.
• Confirm the approach is strictly percutaneous; if an open incision was made, a different approach value would be assigned.
• Ensure the documentation explicitly supports the use of a new technology agent and its classification within Group 8.